Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

250
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
250
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Group Design02:01

Group Design

10.6K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.6K
Factorial Design02:01

Factorial Design

13.9K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SMART-of-1 approach to personalized treatment trials.

Journal of biopharmaceutical statistics·2026
Same author

Combat injury, pain, and mental health outcomes in US Army service members.

Psychological medicine·2026
Same author

Bayesian Response-Adaptive Randomization for Cluster Randomized Controlled Trials.

Statistics in medicine·2026
Same author

Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Optimizing and Testing an Individualized and Adaptive Physical Activity Digital Health Intervention: Protocol for a Control Optimization Trial Embedded Within a Randomized Controlled Trial.

JMIR research protocols·2025
Same author

The Effect of Severe Sepsis and Septic Shock Management Bundle (SEP-1) Compliance and Implementation on Mortality Among Patients With Sepsis : A Systematic Review.

Annals of internal medicine·2025

Related Experiment Video

Updated: Feb 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Preference-Informed Cluster Randomized Design for Pragmatic Clinical Trials.

Yuwei Cheng1, Adriana Tremoulet2, Sonia Jain1,3

  • 1Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.

Statistics in Medicine
|February 5, 2026
PubMed
Summary
This summary is machine-generated.

Cluster randomized trials (CRTs) often face non-adherence due to patient preferences. A new Bayesian model (PICRD) effectively analyzes CRTs with treatment switching, improving power and reducing bias in pragmatic research.

Keywords:
Bayesian approachMarkov chain Monte Carloclinical trial designcluster randomized trialspreference design

More Related Videos

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.6K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Related Experiment Videos

Last Updated: Feb 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.6K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Public Health Research

Background:

  • Cluster randomized trials (CRTs) are essential for pragmatic research but vulnerable to treatment non-adherence.
  • Cluster-level preferences can lead to deviations from assigned treatments, impacting trial validity.
  • Kawasaki Disease trials face challenges with institutional preferences influencing participation and adherence.

Purpose of the Study:

  • To propose and evaluate a Bayesian hierarchical model for CRTs with non-adherence.
  • To address treatment switching influenced by cluster-level preferences in pragmatic trials.
  • To improve the analysis of CRTs when adherence to randomization is unrealistic.

Main Methods:

  • Developed a Preference-Informed Cluster Randomized Design (PICRD) using a Bayesian hierarchical model.
  • Explicitly incorporated cluster-level treatment switching into the analysis framework.
  • Conducted simulation studies to assess model performance under various switching proportions and effect sizes.

Main Results:

  • The PICRD model demonstrated superior performance compared to per-protocol analyses.
  • PICRD maintained higher statistical power for detecting treatment effects.
  • The model produced narrower credible intervals and more stable bias and RMSE metrics.

Conclusions:

  • The PICRD approach offers a flexible and robust solution for analyzing CRTs in pragmatic settings.
  • Explicitly modeling preference and treatment switching enhances the validity of CRT findings.
  • This method is crucial for real-world trials where perfect adherence is uncommon.